[METABOLIC DISORDERS IN INOPERABLE CANCER AND THEIR TREATMENT BY INHIBITORS].
D000970:Antineoplastic Agents; D007611:Aprotinin; D004791:Enzyme Inhibitors; D007610:Kallikreins; D008659:Metabolic Diseases; D009369:Neoplasms / Q000532:radiotherapy* / Q000628:therapy*; D011832:Radiation Injuries; D014116:Toxicology; D014357:Trypsin
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D007611:Aprotinin; D007610:Kallikreins; D014357:Trypsin
ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; KALLIKREIN; KALLIKREIN-TRYPSIN INACTIVATOR; METABOLIC DISEASES; NEOPLASM RADIOTHERAPY; NEOPLASM THERAPY; RADIATION INJURY; TOXICOLOGIC REPORT; TRYPSIN
STOFFWECHSELSTOERUNGEN BEI INOPERABLEN CARCINOMEN UND IHRE BEHANDLUNG MIT INHIBITOREN.